Literature DB >> 27682013

Regulation of Siglec-8-induced intracellular reactive oxygen species production and eosinophil cell death by Src family kinases.

Gen Kano1, Bruce S Bochner2, Nives Zimmermann3.   

Abstract

RATIONALE: Siglec-8 is a surface receptor predominantly expressed on human eosinophils where its ligation induces reactive oxygen species (ROS) formation and cell death. Since Siglec-8 has intracellular tyrosine-based motifs, we hypothesized that Src family kinases (SFKs) are involved in ROS formation and cell death induced by Siglec-8 engagement.
METHODS: Human peripheral blood eosinophils were purified and incubated with anti-Siglec-8 monoclonal antibodies (mAb, agonist), IL-5, and SFK pharmacological inhibitors. We focused on Siglec-8-induced cell death in short-term IL-5-activated cells leading to a regulated necrosis-type cell death. ROS production was determined by dihydrorhodamine (DHR) 123 labeling and flow cytometry, or by chemiluminescence using Amplex red. Activation of SFK was determined using phospholuminex and Western blotting.
RESULTS: In order to determine cellular localization of ROS production, we measured intra and extracellular ROS. While an ETosis stimulus (calcium ionophore A23187) led to extracellular ROS (ecROS) production, Siglec-8-engagement in short-term IL-5 activated cells led to intracellular ROS (icROS) accumulation. Consistently, inhibition of extracellular ROS by catalase inhibited ETosis, but not IL-5-primed Siglec-8-induced cell death. In order to determine signaling events for Siglec-8, we performed Western blotting and found SFK phosphorylation in lysates from eosinophils stimulated with anti-Siglec-8 mAb±IL-5. In order to identify which SFKs were involved, we used the phospholuminex assay and found increased levels of phosphorylated Fgr in the cytoplasmic fraction of cells co-stimulated with anti-Siglec-8 and IL-5 for 3 hours compared with cells stimulated with IL-5 alone. To test the involvement of SFKs in ROS production and cell death, we used SFK inhibitors PP2 and dasatinib, both of which completely inhibited eosinophil ROS production and cell death induced by anti-Siglec-8 and IL-5 co-stimulation.
CONCLUSION: Siglec-8 engagement in short-term IL-5-activated eosinophils causes icROS production and SKF phosphorylation, and both are essential in mediating Siglec-8-induced cell death.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Cell death; Eosinophils

Mesh:

Substances:

Year:  2016        PMID: 27682013      PMCID: PMC5154890          DOI: 10.1016/j.imbio.2016.09.006

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  32 in total

1.  Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury.

Authors:  Esra Nutku; Sherry A Hudson; Bruce S Bochner
Journal:  Biochem Biophys Res Commun       Date:  2005-10-28       Impact factor: 3.575

2.  ROS-triggered phosphorylation of complex II by Fgr kinase regulates cellular adaptation to fuel use.

Authors:  Rebeca Acín-Pérez; Isabel Carrascoso; Francesc Baixauli; Marta Roche-Molina; Ana Latorre-Pellicer; Patricio Fernández-Silva; María Mittelbrunn; Francisco Sanchez-Madrid; Acisclo Pérez-Martos; Clifford A Lowell; Giovanni Manfredi; José Antonio Enríquez
Journal:  Cell Metab       Date:  2014-05-22       Impact factor: 27.287

3.  Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1.

Authors:  Benjamin E Tourdot; Michelle K Brenner; Kathleen C Keough; Trudy Holyst; Peter J Newman; Debra K Newman
Journal:  Biochemistry       Date:  2013-04-03       Impact factor: 3.162

Review 4.  Siglec-mediated regulation of immune cell function in disease.

Authors:  Matthew S Macauley; Paul R Crocker; James C Paulson
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

5.  cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production.

Authors:  N Vanlangenakker; T Vanden Berghe; P Bogaert; B Laukens; K Zobel; K Deshayes; D Vucic; S Fulda; P Vandenabeele; M J M Bertrand
Journal:  Cell Death Differ       Date:  2010-11-05       Impact factor: 15.828

Review 6.  Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.

Authors:  Takumi Kiwamoto; Norihito Kawasaki; James C Paulson; Bruce S Bochner
Journal:  Pharmacol Ther       Date:  2012-06-27       Impact factor: 12.310

7.  Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis.

Authors:  Esra Nutku; Hideyuki Aizawa; Sherry A Hudson; Bruce S Bochner
Journal:  Blood       Date:  2003-02-27       Impact factor: 22.113

8.  Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis.

Authors:  Takumi Kiwamoto; Toshihiko Katoh; Michael Tiemeyer; Bruce S Bochner; Christopher M Evans; William J Janssen; Mary E Brummet; Sherry A Hudson; Zhou Zhu
Journal:  J Allergy Clin Immunol       Date:  2014-12-12       Impact factor: 10.793

9.  Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells.

Authors:  Ramin Lotfi; Gloria Isabelle Herzog; Richard Anthony DeMarco; Donna Beer-Stolz; James Joseph Lee; Anna Rubartelli; Hubert Schrezenmeier; Michael Thomas Lotze
Journal:  J Immunol       Date:  2009-09-30       Impact factor: 5.422

10.  Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans.

Authors:  Shigeharu Ueki; Rossana C N Melo; Ionita Ghiran; Lisa A Spencer; Ann M Dvorak; Peter F Weller
Journal:  Blood       Date:  2013-01-09       Impact factor: 22.113

View more
  6 in total

1.  Characterization of Siglec-8 Expression on Lavage Cells after Segmental Lung Allergen Challenge.

Authors:  Mats W Johansson; Elizabeth A Kelly; Christopher L Nguyen; Nizar N Jarjour; Bruce S Bochner
Journal:  Int Arch Allergy Immunol       Date:  2018-06-07       Impact factor: 2.749

2.  Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating β2-integrin-dependent function in human eosinophils.

Authors:  Daniela J Carroll; Jeremy A O'Sullivan; David B Nix; Yun Cao; Michael Tiemeyer; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2017-09-06       Impact factor: 10.793

3.  Administration of vitamin E attenuates airway inflammation through restoration of Nrf2 in a mouse model of asthma.

Authors:  Quang Luu Quoc; Tra Cao Thi Bich; Seo-Hee Kim; Hae-Sim Park; Yoo Seob Shin
Journal:  J Cell Mol Med       Date:  2021-06-04       Impact factor: 5.310

Review 4.  Recent advances in understanding eosinophil biology.

Authors:  Amy Klion
Journal:  F1000Res       Date:  2017-07-07

Review 5.  Glycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding Proteins.

Authors:  Jeremy A O'Sullivan; Daniela J Carroll; Bruce S Bochner
Journal:  Front Med (Lausanne)       Date:  2017-08-02

6.  Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death In Vitro.

Authors:  Daniela J Carroll; Yun Cao; Bruce S Bochner; Jeremy A O'Sullivan
Journal:  Front Immunol       Date:  2021-10-11       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.